NIH Women's Health Researchers Rebut Criticisms Of Their Study

Project scientists reject Institute of Medicine claims that their ambitious initiative is scientifically and financially deficient One of the main questions that Women's Health Initiative (WHI) investigators hope to answer, and one specifically challenged by the Institute of Medicine (IOM), is whether a low-fat diet will reduce breast cancer risk. This hypothesis arises from comparisons of epidemiological data from countries with

| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Project scientists reject Institute of Medicine claims that their ambitious initiative is scientifically and financially deficient One of the main questions that Women's Health Initiative (WHI) investigators hope to answer, and one specifically challenged by the Institute of Medicine (IOM), is whether a low-fat diet will reduce breast cancer risk. This hypothesis arises from comparisons of epidemiological data from countries with different fat-consumption patterns and of data tracking the change in breast cancer occurrence among migrants moving between some of these countries. Japanese women, for example, have much lower breast cancer rates than do women in the United States, and the traditional Japanese diet contains much less fat than is the norm in the U.S. Women whose parents moved from Japan to the U.S. have breast cancer rates comparable with those of other women in the U.S. The IOM report, however, suggested that these comparisons are based on the amount ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Franklin Hoke

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours